W Endoluminal Robotics
Early Diagnosis and Treatment of Lung Cancer
StartupW Endoluminal Robotics is a startup in the Health Tech & Life Sciences sector, established in 2020. Early Diagnosis and Treatment of Lung Cancer. The company has raised a total of $260K across 2 funding rounds, currently at the Seed stage. W Endoluminal Robotics was founded by Prof. Nir Shvalb. Key investors include Peregrine Ventures. The company has 1-10 employees. Core technologies: Machinery & Robotics.
With $260K in total funding, W Endoluminal Robotics is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQIsrael
- Last Round$260K
- Peregrine Ventures
Prof. Nir ShvalbFounder
What does W Endoluminal Robotics do?
W Endoluminal Robotics is developing a solution for the early diagnosis and treatment of lung cancer. Its novel mechanical solution and advanced control algorithms enable limitless accessibility to every location within the lungs, with true live confirmation. The company’s technology is revolutionizing diagnostics by increasing certainty in lung biopsies and enabling advanced lung treatment solutions, offering an innovative approach designed to surpass other advanced technologies while reducing the burden on hospitals.
How much funding has W Endoluminal Robotics raised?
W Endoluminal Robotics has raised $260K in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Peregrine Ventures.
Who founded W Endoluminal Robotics?
W Endoluminal Robotics was founded in 2020 by Prof. Nir Shvalb (Founder).
What sector is W Endoluminal Robotics in?
W Endoluminal Robotics operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, with core technologies in Machinery & Robotics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is W Endoluminal Robotics located?
W Endoluminal Robotics is based in Israel.